A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East
NCT07215975
·
clinicaltrials.gov ↗
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
β-thalassemia
Interventions
DRUG:
Luspatercept
Sponsor
Bristol-Myers Squibb